Friday, April 26, 2024

12:15 PM to 1:45 PM ET
*Doors open at 11:45 AM for check in and lunch with education starting at 12:15 PM.
 
Symposium will be held during the Oncology Nursing Society's (ONS) 49th Annual Congress. Participants must be registered for the ONS Annual Congress in order to attend this session. 
 
Marriott Marquis Washington DC
901 Massachusetts Avenue
Washington, DC 20001
 
Marquis Ballroom Salon 6-10, Meeting Level 2 (M2)
 

Target Audience:

This CE activity is intended for oncology nurses and nurse practitioners involved in the care of patients with hematologic malignancies.

Description:

Compete with your colleagues to win prizes and earn free CE credit, as you expand your knowledge on the availability and application of CAR T-cell and bispecific therapies to treat patients with hematologic malignancies. Follow a patient from diagnosis, through therapy, and follow-up monitoring while providing input on the patient's care! Learn about the newest treatments, safety and efficacy, patient management, barriers to access/care, resources for patient education and support from The Leukemia & Lymphoma Society, and more in this interactive session, all to improve patient care!

Learning Objectives:

Upon completion, participants should be better able to:

  • Describe the role of CAR T-cell therapy and bispecifics in treating blood cancer
  • Apply knowledge of communication strategies, streamlined patient assessment, disparities in care, and strategies for multidisciplinary teams to improve patient-centered care
  • Explain data surrounding CAR T-cell and bispecific therapies including their proper application, efficacy, and adverse events, and resources to support patients and their caregivers
  • Optimize patient assessment to ensure effective, individualized patient care, including implementation of bridging therapy when indicated
  • Utilize appropriate tools to properly assess risk for progression and response to cellular therapies

Speakers:

Jessica R. Kassay-McAllister, DNP, RN, AGACNP-BC
Oncology APP Manager
Division of Hematology/Oncology
Cellular Therapy/Stem Cell Transplant Program, Effector Cell NP
UVA School of Nursing Clinical Faculty
University of Virginia Comprehensive Cancer Center
Charlottesville, VA
 
Krithika Shanmugasundaram, MD
Assistant Professor of Medicine, Division of Hematology/Oncology
University of Virginia Comprehensive Cancer Center
Charlottesville, VA
 
Dan Vogl, MD, MSCE
Director, Abramson Cancer Center Clinical Research Unit
Associate Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA
 

 


 

This activity is provided by The Leukemia & Lymphoma Society.

Supported by an educational grant from Bristol Myers Squibb.

There is no fee for this program, but registration is required.

Meeting space has been assigned to provide a symposium supported by The Leukemia & Lymphoma Society during the Oncology Nursing Society’s (ONS) 49th Annual Congress, April 24 – April 28, 2024 in Washington, DC. The Oncology Nursing Society's assignment of meeting space does not imply product endorsement.

For questions, concerns, grievances, or assistance for people with disabilities, please contact us at: profeducation@LLS.org.

 

Follow LLS